Speak to patients and caregivers in their language
LINK® helps you efficiently develop, translate, and publish plain language summaries to meet increasing compliance requirements and the growing public demand for non-technical clinical trial information.
#BeTransparent with clinical trial summaries patients can actually understand
Plain language summaries enhance trial participants’ access to information, ensure compliance and improve your Good Pharma Scorecard rankings.
Encapsulate any clinical study in short, easy-to-understand, plain language format
Create ready-to-review summaries
Writing plain language summaries from scratch takes weeks. Now LINK® can do the work for you.
By transforming information from existing sources, TrialAssure’s LINK software generates lay summary language ready for review and editing through advanced machine learning. Sponsors routinely cut 4+ weeks from the process and enable greater transparency and patient engagement.
LINK® also serves as a comprehensive project management solution for plain language summaries.
- Collaborate with remote team members on summary content
- Track status of each summary and log approvals
- Automatically publish summaries to an online portal with a single click
Meet global transparency demands
More and more countries are requiring lay summaries, and investigational sites and participants around the world value them. That means language needs are rapidly diversifying.
Fortunately, LINK® can help you create summary translations that are linguistically, culturally, and contextually accurate.
Plain Language Summaries with Even Less Hassle
Want to reduce the lay summary workload further? You have to see it to believe it. Talk with one of our experts to see a demo and make clinical trial participant communications easier.
Download Our Lay Summaries White Paper
Getting started with plain language summaries
This complimentary white paper will explain the ins and outs of lay summary writing, the importance of starting a pilot program, a checklist for lay reviewers, and strategic advice for becoming more transparent.